Biofil Chemicals Intrinsic Value
Biofil Chemicals (BIOFILCHEM) median intrinsic value is ₹12.82 from 9 valuation models (range ₹10–₹44), vs current price ₹32.06 — -60.0% downside (Trading Above Calculated Value), margin of safety -100.0%. Read BIOFILCHEM ex-dividend dates for the complete payout history and dividend yield track record.
BIOFILCHEM Valuation Methods Summary — DCF, Graham Number & P/E
Biofil Chemicals intrinsic value across 9 models vs current price ₹32.06 — upside/downside and value range per method. Compare with BIOFILCHEM fundamental valuation to assess whether the stock is under or overvalued.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹9.62 | ₹7.70 - ₹11.54 | -70.0% | EPS: ₹0.30, Sector P/E: 22x |
| Book Value Method | asset | ₹23.75 | ₹21.38 - ₹26.13 | -25.9% | Book Value/Share: ₹11.88, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹43.75 | ₹39.38 - ₹48.13 | +36.5% | Revenue/Share: ₹21.88, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹12.82 | ₹11.54 - ₹14.10 | -60.0% | EBITDA: ₹1.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹16.98 | ₹13.58 - ₹20.38 | -47.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹9.62 | ₹8.66 - ₹10.58 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹9.62 | ₹8.66 - ₹10.58 | -70.0% | Revenue Growth: 3.9%, Adj P/E: 15.3x |
| ROE Based Valuation | profitability | ₹16.03 | ₹14.43 - ₹17.63 | -50.0% | ROE: 5.3%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹9.62 | ₹8.66 - ₹10.58 | -70.0% | EPS: ₹0.30, BVPS: ₹11.88 |
BIOFILCHEM Intrinsic Value vs Market Price — All Valuation Models
Biofil Chemicals fair value range ₹10–₹44 vs current market price ₹32.06 across 9 valuation models. For current market price and key ratios, visit Biofil Chemicals stock price NSE.
BIOFILCHEM Intrinsic Value Analysis — Undervalued or Overvalued?
Biofil Chemicals median intrinsic value ₹12.82, current price ₹32.06 — Trading Above Calculated Value by 60.0%, margin of safety -100.0%.
What is the intrinsic value of BIOFILCHEM?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Biofil Chemicals (BIOFILCHEM) is ₹12.82 (median value). With the current market price of ₹32.06, this represents a -60.0% variance from our estimated fair value.
The valuation range spans from ₹9.62 to ₹43.75, indicating ₹9.62 - ₹43.75.
Is BIOFILCHEM undervalued or overvalued?
Based on our multi-method analysis, Biofil Chemicals (BIOFILCHEM) appears to be trading above calculated value by approximately 60.0%.
BIOFILCHEM Financial Health — Key Ratios vs Industry Benchmarks
Biofil Chemicals financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Return on Equity | 5.3% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 5.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.69x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
BIOFILCHEM Cash Flow Quality — Operating & Free Cash Flow
Biofil Chemicals operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-2 Cr | ₹-2 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹2 Cr | ₹2 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 8/10 |